ePTFE covering for endovascular prostheses and method of manufacture
First Claim
1. An implantable composite device for regulating delivery of bioactive agents associated therewith to a site of implantation of said device comprising:
- (a) a luminal zone of first porosity; and
(b) a second zone of second porosity overlying said luminal zone, said second zone permitting regulated transport of said bioactive agents therethrough.
4 Assignments
0 Petitions
Accused Products
Abstract
An implantable composite device for regulated delivery of bioactive agents to the site of implantation includes at least two zones of distinct porosities through its cross-section. One zone is of a sufficient porosity to permit regulated transport of bioactive agents associated with the device to an area of the body in need of treatment. The bioactive agent associated with the device can be either a therapeutic or diagnostic agent. In a particular embodiment of the invention, the device includes a tubular body consisting of a first luminal layer of ePTFE having a porosity sufficient to promote cell endothelization along the luminal surface; and a second polymeric layer disposed on the first layer of a porosity permitting regulated transport of the bioactive agents.
215 Citations
75 Claims
-
1. An implantable composite device for regulating delivery of bioactive agents associated therewith to a site of implantation of said device comprising:
- (a) a luminal zone of first porosity; and
(b) a second zone of second porosity overlying said luminal zone, said second zone permitting regulated transport of said bioactive agents therethrough. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
- (a) a luminal zone of first porosity; and
-
15. An implantable composite device for regulating delivery of bioactive agents associated therewith to a site of implantation of said device comprising:
- (a) a first luminal layer of ePTFE having a first porosity sufficient to promote cell endothelization therealong; and
(b) a second polymeric layer disposed on said first layer, said second layer having a second porosity permitting regulated transport of said bioactive agents therethrough. - View Dependent Claims (16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)
- (a) a first luminal layer of ePTFE having a first porosity sufficient to promote cell endothelization therealong; and
-
39. An implantable composite device for regulating delivery of bioactive agents associated therewith to a site of implantation of said device comprising:
-
(a) a first luminal layer of ePTFE having pores of an internodal distance of greater than 40 microns; and
(b) a second layer of ePTFE disposed on said first layer, said second layer having pores of an internodal distance from about 5 to about 10 microns and a specific node/fibril geometry of about 5 to about 10 microns, the second layer permitting regulated transport of natural or synthetic bioactive agents therethrough. - View Dependent Claims (40, 41, 42, 43, 44, 45)
-
-
46. An implantable composite device for regulating delivery of bioactive agents to a site of implantation of said device comprising:
-
(a) a first layer of ePTFE having pores of an internodal distance of less than 40 microns; and
(b) a second layer of ePTFE disposed on said first layer, said second layer having pores of an internodal distance from about 5 to about 10 microns and a specific node/fibril geometry of about 5 to about 10 microns, the second layer permitting regulated transport of natural or synthetic bioactive agents therethrough. - View Dependent Claims (47, 48, 49, 50, 51, 52)
-
-
53. A method of making an implantable composite device for regulating delivery of bioactive agents associated therewith to a site of implantation of said device, said method comprising:
-
providing a first luminal layer of ePTFE material of a first porosity; and
disposing a second layer of a natural or synthetic polymeric material of a second porosity onto said first layer, said second layer permitting regulated transport of said bioactive agents therethrough. - View Dependent Claims (54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75)
-
Specification